Why An ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Buyout Is Likely After Surprisingly Strong Nuplazid Sales

By: BNL Staff - August 8, 2017 2:43 AM

Strong Nuplazid sales confirm that off label usage is very likely, thereby making Acadia Pharmaceuticals (NASDAQ:ACAD) a likely buyout opportunity.

Also posted in HADE Platform, Healthcare & Biotech, Mergers & Acquisitions

3 Takeaways From XPO Logistics Inc (NYSE:XPO) Q2 Earnings & Conference Call

By: Brian Nichols - August 2, 2017 2:43 AM

XPO Logistics Inc (NYSE:XPO) plans to spend $8 billion and expand last mile. Here’s what XPO stock owners need to know from Q2 earnings.

Also posted in HADE Platform, Hot Stocks, Industrials

Update For BNL Members: Big Transition Coming

By: Brian Nichols - July 31, 2017 2:43 AM

Talking HADE update, changes, and big additions.

Also posted in Editor's Pick, HADE Platform

What $8 Billion In Acquisitions Will Mean For XPO Logistics (NYSE:XPO) Stock Owners

By: Brian Nichols - July 25, 2017 2:43 AM

3 scenarios and factors affecting the outlook for XPO stock and XPO Logistics Inc (NYSE:XPO) as Bradley Jacobs prepares for shopping spree.

Also posted in Basic Materials, Hot Stocks, Mergers & Acquisitions

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock: Is It Too Late to Buy?

By: BNL Staff - July 21, 2017 2:43 AM

VRTX stock may have little upside, but a Gilead Sciences (NASDAQ:GILD) buyout of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) could be in play.

Also posted in HADE Platform, Healthcare & Biotech, Hot Stocks, Mergers & Acquisitions

Rite Aid Corporation Keeps Its Better Half: What’s It Mean For RAD Stock?

By: Brian Nichols - July 18, 2017 2:43 AM

Rite Aid Corporation’s pro forma disclosure of what’s left after the Walgreens deal confirms our previous conclusion, that RAD stock is a no-brainer.

Also posted in Healthcare & Biotech, Mergers & Acquisitions